ABOUT US
QIAGEN pushes the boundaries of innovation to improve our understanding of DNA, RNA and proteins – the building blocks of life. We enable our customers to unlock valuable insights from any biological sample – be it blood, a throat swab or many other materials. Our products serve a wide range of applications, including cell and gene therapy. In this space, customers can find solutions for precise determination of plasmid quality, viral titer, vector copy number and robust contaminant testing. Our reputation is based on confidence in decisions, clarity of results and pride in the insights our customers achieve. More than 35 Nobel Prize winners among more than 500,000 customers worldwide are proof of that success. Together, we are making improvements in life possible.
FEATURED ARTICLES
-
![GettyImages-2190247072-laboratory-vials-analysis-scientist]( "Optimized Urine Liquid Biopsy Workflow")
Urine-derived cell-free DNA is revolutionizing liquid biopsy research to offer a non-invasive, accessible tool for early disease detection, monitoring, and comprehensive diagnostics across oncology.
-
![GettyImages-1746637448-laboratory-tablet-analysis-vial]( "Liquid Biopsy-Based Detection Of PIK3CA Mutations From cfDNA")
Discover how ultra-sensitive digital PCR workflows use an innovative system to enable precise detection of rare PIK3CA mutations in cfDNA and advance personalized cancer treatment.
-
![GettyImages-2156218287-vial-blood-sample-liquid-biopsy]( "Detect Ultra-Rare Variants In cfDNA From Liquid Biopsy Samples")
Liquid biopsy, powered by next-generation sequencing, is transforming precision oncology to offer real-time, non-invasive insights into tumor genetics, which revolutionizes how we monitor and manage cancer.
-
![GettyImages-2181934436-laboratory-analysis-scientists-technology-computer]( "Quantifying Lentiviral Physical Titer")
Streamline lentiviral vector analytics with our direct RT-dPCR method. Achieve precise, reproducible results to accelerate safe, effective gene therapies with enhanced quality control.
-
![GettyImages-2194013542-scientists-smiling-in-lab-discussing]( "Advancements In Gene Therapy Development")
Gene therapy is transforming treatment for genetic disorders. With over 30 FDA-approved therapies, gain expert insight into how digital PCR enhances AAV vector precision, safety, and regulatory compliance in development.
-
![Adeno-associated viruses AAV GettyImages-1322096218]( "A Duplex Assay For Quantification And Qualification Of AAV")
Adeno-associated virus is a key gene therapy vector. Explore how digital PCR offers precise, standard-free quantification with improved consistency and inhibitor tolerance over traditional qPCR methods.
-
![GettyImages-1595648709-pipette-laboratory-assay-cell-culture]( "Quantification And Qualification Of Adeno-Associated Virus")
Explore how digital PCR technologies offer precise, reproducible AAV quantification to address qPCR limitations with streamlined workflows and dedicated CGT assays to support safe, consistent gene therapy development.
-
![GettyImages-1165637777 DNA]( "Analysis Of DNA Integrity And Stability Using Digital PCR")
Digital PCR offers precise, inhibitor-resistant DNA quantification and genome integrity assessment. Discover how this method enhances accuracy and reproducibility, especially in AAV analysis, using multiplexed targets and Poisson-based calculations.
CONTACT INFORMATION
QIAGEN
QIAGEN Strasse 1
Hilden, 40724
GERMANY
Contact: https://www.qiagen.com/us/contact-us
FEATURED WEBINARS
-
![Streamlined dPCR Workflow For Lentiviral Characterization]( "Streamlined dPCR Workflow For Lentiviral Characterization")
Discover a streamlined dPCR-based workflow for precise lentiviral vector quantification to support safer, more consistent cell and gene therapies through accurate genome titer, VCN, and RCL assessment.
-
![From Discovery To Verification]( "Unlocking miRNA Biomarkers With NGS And Digital PCR")
Discover how next-generation sequencing and digital PCR enable miRNA biomarker discovery and validation. Learn best practices for sample prep, data analysis, and assay design to advance RNA research.
-
![Advancements In Genome Integrity Assessment For Vector-Based Gene Therapies]( "Advancements In Genome Integrity Assessment For Gene Therapies")
Gene therapy holds promise for treating various genetic diseases. Explore the latest in gene therapy with expert insights on AAV vector integrity, dPCR-based solutions, assay design, and reference standards.
-
![Triplex RT-dPCR Method For A Safety Study In Drug Development]( "Triplex RT-dPCR Method For A Safety Study In Drug Development")
Discover how an innovative technology harnesses natural RNA editing with EONs and digital PCR to precisely correct mutations, which offers a novel approach to treating genetic diseases.
-
![Enhancing Preclinical Research Precision]( "Analyzing CAR-T Biodistribution With Digital PCR (dPCR)")
Explore a novel dPCR workflow for tracking CAR-T and leukemia cell biodistribution in rodents that enhances precision, sensitivity, and reliability in preclinical assessments of investigational cell therapies.
